Top Markets
#1 Helium Helium +57.91%
#2 Seeker Seeker +52.99%
#3 Zylo Ecosystem Zylo Ecosystem +40.15%
#4 UnifAI Network UnifAI Network +27.96%
#5 Pons Pons +25.79%
#6 TENDIES TENDIES +22.86%
#7 Bounce Bounce +16.46%
#8 Songbird Songbird +14.89%
#9 pipedog pipedog +13.57%
#10 DAPPOS DAPPOS +13.24%
Coin of the day
Helium Helium
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
BioSig Technologies, Inc. BioSig Technologies, Inc.

BioSig Technologies, Inc.

BSGM
Rang in Aktien #10875
BioSig Technologies, Inc., along with its subsidiaries, operates as a medical... BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering electrophysiologists to instantaneously view and analyze vital cardiac signals. The system further enhances the collection of intracardiac signals and diagnostic data crucial for atrial fibrillation procedures. Moreover, it is specifically engineered to overcome persistent obstacles that traditionally slow down and complicate cardiac catheter ablation. BioSig also holds a research agreement with the University of Minnesota, targeting the development of new treatments for sympathetic nervous system disorders. Additionally, it has a strategic partnership with the Mayo Foundation for Medical Education and Research, focused on creating an advanced AI and machine learning software solution tailored for its PURE EP platforms. Established in 2009, BioSig Technologies, Inc. is headquartered in Westport, Connecticut.
Aktienkurs
$5.52
Zuletzt synchronisiert: 2025-10-09
Marktkapitalisierung
$775.10M
Veränderung (1 Tag)
1.28%
Veränderung (1 Jahr)
15.48%
Land
US
Handel BioSig Technologies, Inc. (BSGM)

Kategorie

Healthcare
Operative Marge für BioSig Technologies, Inc. (BSGM)
Operative Marge zum August 2026 TTM: 0.00%
Laut den neuesten Finanzberichten und dem Aktienkurs von BioSig Technologies, Inc. beträgt die aktuelle operative Marge (TTM) 0.00%. Am Ende des Jahres 2023 lag die operative Marge bei -158,400.00%.
Historie der operativen Marge von BioSig Technologies, Inc. von 2011 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 0.00% -100.00%
2024 -32,155.00% -79.70%
2023 -158,400.00% 1,561.56%
2022 -9,533.22% 25.83%
2021 -7,576.19% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00% -
DE
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.